Životopis/Biography

Branimir I. (Brandy) Sikic
 
Official Contact Inforamtion
Institution: Standford University Medical Center
Department Name: Oncology Division
Position : Program Director, General Clinical Research Center ; Professor of Medicine (Oncology and Clinical Pharmacology); Director, Cancer Clinical Trials Office
Street And Number : CCSR North 1105 ,  Stanford, CA 94305-5151 ,  United States
Official Phone ,  Official Fax : (650) 725-6427 ,  (650) 736-1454
E-mail brandy@ stanford.edu
Web http://www-med.stanford.edu/school/sikic/
  oncology (clinical medical sciences .Biomedicine and Public Health)
Education
1979
Medical Oncology Clinical Fellow, Georgetown University Hospital , 
, 
1977 MD
National Cancer Institute, ,  Research Associate, Drug Interactions Section (Dr. Ted Gram), ,  Developmental Therapeutics Program, NIH, Bethesda
, 
1975
Georgetown University Hospital ,  Intern and Resident in Internal Medicine
, 
1972 M. D.,
University of Chicago School of Medicine , 
Chicago , 
1968 B. S.
Georgetown University ,  (Biology, Fine Arts),
Washington ,  United States
Employment Positions
1998 - 2004 Director,
Cancer Clinical Trials Office, Stanford University Medical Center ,  , 

1997 - 2004 Professor of Medicine
(Oncology and Clinical Pharmacology), Stanford University School of Medicine ,  , 

1993 - 2004 Program Director,
General Clinical Research Center, Stanford University School of Medicine and Stanford University Hospital ,  , 

1992 - 1993 Associate Program Director,
General Clinical Research Center, Stanford University School of Medicine and Stanford University Hospital ,  , 

1986 - 1996 Associate Professor of Medicine (Oncology and Clinical Pharmacology),
Stanford University School of Medicine ,  , 

1986 - 1987 Visiting Scientist, Imperial Cancer
Molecular Biology Laboratory (Dr. George Stark), ,  London ,  United Kingdom

1979 - 1986 Assistant Professor of Medicine (Oncology and Clinical Pharmacology),
Stanford University School of Medicine ,  Stanford , 

1977 - 1978 Investigator
Drug Interactions Section, Developmental Therapeutics Program, National Cancer Institute ,  Bethesda , 

Academic Positions
Teaching
2003 AACR Minisymposium, “Mechanisms and Modulation of Drug Resistance,” ,  Co-chairman ,  , 
2003 - 2006 ASCO Multidisciplinary Cancer Management Course Working Group, ,  Member ,  , 
2003 AACR Forum, “Antisense: the Clinical Perspective,” AACR Annual Meeting ,  Chairman ,  , 
2003 John H. Blaffer ,  Visiting Professor, ,  M. D. Anderson Cancer Center ,  , 
2002 AACR Minisymposium, “Transporters and Drug Resistance,” ,  Co-chairman ,  , 
2002 ASCO Integrated Symposium, “New Agents and New Targets,” ,  Co-chairman ,  , 
2002 - 2003 Best Doctors in America, ,  , 
2001 - 2005 Chairman ,  Annual Northern California Tumor Board at Silverado ,  , 
2000 Oncology Teaching Award, ,  Stanford University School of Medicine ,  , 
1999 - 2000 First and Second UCSF Stanford Tumor Boards at Silverado, “A Multidisciplinary Approach to Cancer Treatment,” ,  Chairman ,  , 
1999 Plenary Lecturer ,  Netherlands Cancer Institute Symposium ,  Amsterdam ,  Netherlands, The
1998 - 2004 Central European Oncology Congress, “Advances in Cancer Detection and Treatment,” ,  Chairman and Founder ,  Opatija ,  Croatia (Hrvatska)
1997 Symposium on “Current Treatment and Future Directions in the Management of Lung Cancer and Non-Hodgkin’s Lymphoma,” ,  Chairman ,  San Francisco , 
1997 Plenary Lecturer, ,  Federation of European Biology Societies (FEBS) Course on ABC Transporters ,  Gösau ,  Austria
1993 70th Anniversary of the CRC Lecturer, ,  British Association of Cancer Research ,  London ,  United Kingdom
1992 Pfizer Visiting Professor in Clinical Pharmacology, ,  Visiting Professor ,  Dartmouth Medical School, ,  , 
1990 Warren J. Schneider Memorial Lecturer, ,  University of the Pacific ,  , 
1984 International Conference on Bleomycin Chemotherapy, ,  Co-chair ,  San Francisco , 
1983 - 1985 Oncology Examining Committee, American College of Physicians MKSAP VII Recertifying Course and Examination, ,  Member ,  , 
1981 - 1983 Pharmaceutical Manufacturers Association Foundation ,  Faculty Development Award in Clinical Pharmacology ,  , 
:: :: - :: :: Oncology Section of the “Preparation for Clinical Medicine” course for Second Year Medical Students ,  Director ,  Stanford University ,  , 
Guest teacher
Congres
Projects
Publications
Articles
Serials
Awards
AMAC
----
Memberships All
2004 - 2004 Clinical Research Planning Committee, Department of Medicine, ,  , 
2003 - 2004 Translational Research Planning Committee for the School of Medicine, ,  , 
2003 Clinical Scientific Advisory Board ,  Sunesis Pharmaceuticals, ,  , 
2003 Oncology Advisory Board ,  Johnson and Johnson, ,  , 
2003 - 2006 International Affairs Committee, American Society of Clinical Oncology (ASCO), ,  , 
2002 - 2003 Chairman, Research Policy Review Committee for HIPAA, Stanford University School of Medicine, ,  , 
2002 Oncology Advisory Board ,  Exelixis, Inc., ,  , 
2002 - 2003 Oncology Advisory Board ,  Eli Lilly, Inc., ,  , 
2002 - 2004 Oncology Informatics Steering Committee, Stanford University School of Medicine, ,  , 
2002 - 2004 Task Force on Translational Research at Stanford Medical Center, ,  , 
2001 - 2003 Oncology Advisory Board ,  Celera, Inc., ,  , 
2000 - 2003 Communications Committee, ASCO, ,  , 
1999 - 2003 Appointments and Promotions Committee, Department of Medicine, Stanford University School of Medicine, ,  , 
1999 - 2000 Chairman, Education Committee, American Association for Cancer Research (AACR), ,  , 
1999 - 2001 Oncology Advisory Board (Chair) ,  Axys Pharmaceuticals, Inc., ,  , 
1998 - 2002 Scientific Advisory Board (Chair) ,  Ontogen Corporation, ,  , 
1998 - 2004 Steering Committee, Clinical Cancer Center, Stanford University Medical Center, ,  , 
1997 - 1999 Scientific Advisory Board ,  Rigel Pharmaceuticals, Inc., ,  , 
1997 - 2001 Admissions Committee, Stanford University Program in Cancer Biology, ,  , 
1996 - 2001 Scientific Advisory Board ,  Pharmacyclics, Inc., ,  , 
1996 - 2001 Oncology Advisory Board ,  Isis Pharmaceuticals, Inc., ,  , 
1995 Dean's Executive Subcommittee for the Development of a Gene Therapy Program Stanford University School of Medicine, ,  , 
1995 - 1999 Oncology Advisory Board ,  Glaxo-Wellcome Corporation, ,  , 
1995 - 2002 Scientific Advisor ,  Pfeiffer Medical Research Foundation, ,  , 
1995 Scientific Advisor ,  Margaret E. Early Trust, ,  , 
1992 - 1999 Oncology Advisory Board ,  Novartis (Sandoz) Pharmaceuticals, ,  , 
1992 - 2004 General Clinical Research Center Advisory Committee, Stanford University School of Medicine, ,  , 
1982 - 1984 Chairman, Quality of Care Committee, Medical Service, Stanford Univ. Hospital, ,  , 
1982 - 1986 Compromised Host Committee, Stanford University Hospital, ,  , 
1982 Oncology Advisory Board ,  Bristol-Myers Squibb Company, ,  , 
:: :: - :: :: Western Association of Physicians ,  , 
:: :: - :: :: American College of Physicians ,  , 
:: :: - :: :: American Association for Cancer Research ,  , 
:: :: - :: :: American Society of Clinical Oncology ,  , 
:: :: - :: :: American Federation for Clinical Research ,  , 
:: :: - :: :: Western Society for Clinical Investigation ,  , 
Pool
  NO
Cooperation
   
Expertise
The clinical and pre-clinical pharmacology of antineoplastic drugs:
Mechanisms of anti-cancer drug action and resistance
Multidrug resistance genes
Tubulin targeted agents
Anti-cancer drug discovery and development
New approaches to cancer therapy:
Antisense DNA pharmacology
Growth factor inhibition combined with chemotherapy
Gene expression profiling to define prognostic factors and cancer biology:
Current projects include studies of ovarian and testicular carcinomas, unknown primary cancers, and pediatric acute myeloid leukemias
Pharmacogenomics:
Gene expression profiling as a tool to assess cellular responses to anticancer agents